Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus

Gebrehiwot Gebremedhin Tafere, Dawit Zewdu Wondafrash, Kaleab Alemayehu Zewdie, Brhane Teklebrhan Assefa, Muluken Altaye Ayza Department of Pharmacology and Toxicology, School of Pharmacy, Mekelle University, Mekelle, EthiopiaCorrespondence: Gebrehiwot Gebremedhin TafereDepartment of Pharmacology an...

Full description

Bibliographic Details
Main Authors: Tafere GG, Wondafrash DZ, Zewdie KA, Assefa BT, Ayza MA
Format: Article
Language:English
Published: Dove Medical Press 2020-05-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
Online Access:https://www.dovepress.com/plasma-adipsin-as-a-biomarker-and-its-implication-in-type-2-diabetes-m-peer-reviewed-article-DMSO
_version_ 1797935095038869504
author Tafere GG
Wondafrash DZ
Zewdie KA
Assefa BT
Ayza MA
author_facet Tafere GG
Wondafrash DZ
Zewdie KA
Assefa BT
Ayza MA
author_sort Tafere GG
collection DOAJ
description Gebrehiwot Gebremedhin Tafere, Dawit Zewdu Wondafrash, Kaleab Alemayehu Zewdie, Brhane Teklebrhan Assefa, Muluken Altaye Ayza Department of Pharmacology and Toxicology, School of Pharmacy, Mekelle University, Mekelle, EthiopiaCorrespondence: Gebrehiwot Gebremedhin TafereDepartment of Pharmacology and Toxicology,School of Pharmacy, Mekelle University, P.O. Box: 1871, Mekelle, EthiopiaTel +251 908822323Email gebrehiwotg07@gmail.comAbstract: Diabetes mellitus (DM) is a worldwide health threat affecting millions of people, which is associated with different micro- and macro-vascular complications. Type 2 diabetes mellitus (T2DM) is one of the different types of DM caused by insulin resistance and/or reduced secretion of insulin from the pancreas. A validated novel biomarker is required to enhance the accuracy of disease prediction, provide novel insights into pathophysiology and contribute to future prevention of T2DM. Various newer diagnostic methods have been developed by targeting endogenous proteins among which Adipsin is one of the promising target. Therefore, this review discusses Adipsin as a potential biomarker and its implication in T2DM. Adipsin is one of the adipokines secreted by adipose tissues which is involved in maintaining adipose tissue homeostasis and increasing insulin secretion in response to glucose. According to different experimental and clinical studies, plasma Adipsin concentrations are low in animals and patients with DM which support its use as a biomarker in combination to the other diagnostic modalities for DM. Additionally, the existence of Adipsin could be important in improving hyperglycemia by preserving β-cell mass through improving β-cell survival and maintaining their transcriptional identity.Keywords: adipsin, type 2 diabetes mellitus, biomarker
first_indexed 2024-04-10T18:10:03Z
format Article
id doaj.art-169c311a190547a9b9cc3b5da5b28bda
institution Directory Open Access Journal
issn 1178-7007
language English
last_indexed 2024-04-10T18:10:03Z
publishDate 2020-05-01
publisher Dove Medical Press
record_format Article
series Diabetes, Metabolic Syndrome and Obesity
spelling doaj.art-169c311a190547a9b9cc3b5da5b28bda2023-02-02T11:19:39ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072020-05-01Volume 131855186154150Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes MellitusTafere GGWondafrash DZZewdie KAAssefa BTAyza MAGebrehiwot Gebremedhin Tafere, Dawit Zewdu Wondafrash, Kaleab Alemayehu Zewdie, Brhane Teklebrhan Assefa, Muluken Altaye Ayza Department of Pharmacology and Toxicology, School of Pharmacy, Mekelle University, Mekelle, EthiopiaCorrespondence: Gebrehiwot Gebremedhin TafereDepartment of Pharmacology and Toxicology,School of Pharmacy, Mekelle University, P.O. Box: 1871, Mekelle, EthiopiaTel +251 908822323Email gebrehiwotg07@gmail.comAbstract: Diabetes mellitus (DM) is a worldwide health threat affecting millions of people, which is associated with different micro- and macro-vascular complications. Type 2 diabetes mellitus (T2DM) is one of the different types of DM caused by insulin resistance and/or reduced secretion of insulin from the pancreas. A validated novel biomarker is required to enhance the accuracy of disease prediction, provide novel insights into pathophysiology and contribute to future prevention of T2DM. Various newer diagnostic methods have been developed by targeting endogenous proteins among which Adipsin is one of the promising target. Therefore, this review discusses Adipsin as a potential biomarker and its implication in T2DM. Adipsin is one of the adipokines secreted by adipose tissues which is involved in maintaining adipose tissue homeostasis and increasing insulin secretion in response to glucose. According to different experimental and clinical studies, plasma Adipsin concentrations are low in animals and patients with DM which support its use as a biomarker in combination to the other diagnostic modalities for DM. Additionally, the existence of Adipsin could be important in improving hyperglycemia by preserving β-cell mass through improving β-cell survival and maintaining their transcriptional identity.Keywords: adipsin, type 2 diabetes mellitus, biomarkerhttps://www.dovepress.com/plasma-adipsin-as-a-biomarker-and-its-implication-in-type-2-diabetes-m-peer-reviewed-article-DMSOadipsintype2 diabetes mellitusbiomarker
spellingShingle Tafere GG
Wondafrash DZ
Zewdie KA
Assefa BT
Ayza MA
Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
Diabetes, Metabolic Syndrome and Obesity
adipsin
type2 diabetes mellitus
biomarker
title Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
title_full Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
title_fullStr Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
title_full_unstemmed Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
title_short Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
title_sort plasma adipsin as a biomarker and its implication in type 2 diabetes mellitus
topic adipsin
type2 diabetes mellitus
biomarker
url https://www.dovepress.com/plasma-adipsin-as-a-biomarker-and-its-implication-in-type-2-diabetes-m-peer-reviewed-article-DMSO
work_keys_str_mv AT taferegg plasmaadipsinasabiomarkeranditsimplicationintype2diabetesmellitus
AT wondafrashdz plasmaadipsinasabiomarkeranditsimplicationintype2diabetesmellitus
AT zewdieka plasmaadipsinasabiomarkeranditsimplicationintype2diabetesmellitus
AT assefabt plasmaadipsinasabiomarkeranditsimplicationintype2diabetesmellitus
AT ayzama plasmaadipsinasabiomarkeranditsimplicationintype2diabetesmellitus